Primary cutaneous malignancies in black African patients with oculocutaneous albinism in KwaZulu-Natal Province, South Africa
DOI:
https://doi.org/10.7196/SAMJ.2026.v116i2.3821Keywords:
Oculocutaneous albinism, non-melanoma skin cancer, KwaZulu Natal, primary cutaneous malignancyAbstract
Background. Individuals with oculocutaneous albinism (OCA) face a significantly heightened risk of developing skin cancer owing to increased sensitivity to ultraviolet (UV) radiation. Data on the epidemiology and geographical distribution of cutaneous malignancies among persons with albinism (PWA) in KwaZulu-Natal Province (KZN), South Africa, remain limited.
Objective. To investigate the demographic and regional patterns of primary cutaneous malignancies within this high-risk population.
Methods. We conducted a retrospective descriptive analysis of all PWA diagnosed with histologically confirmed primary cutaneous malignancies treated at a tertiary healthcare centre in KZN between January 2002 and June 2022. Sociodemographic, geographical and tumour characteristics were extracted from electronic medical records.
Results. A total of 221 patients (56.6% female, 43.4% male) with a mean (standard deviation) age of 37.9 (12.5) years contributed 618 histologically confirmed malignant lesions. 132/221 patients (59.7%) presented before 40 years of age. Female patients presented slightly earlier (37.1 (12.9 years)) than males (39.0 (12.0 years)). Geographical clustering was observed in eThekwini (43.0%), uMkhanyakude (20.8%) and King Cetshwayo (11.8%) municipalities. Squamous cell carcinoma (SCC) (50.2%) and basal cell carcinoma (BCC) (49.7%) were nearly equally distributed across all the districts; one cutaneous melanoma was identified.
Conclusions. In KZN, PWA tended to develop skin cancer at a younger age than the general population. Notably, the proportions of SCC and BCC were roughly equivalent – a finding that contrasts with historical data, which show a predominance of SCC. The high incidence of skin cancer in coastal and rural districts aligns with elevated ambient UV exposure, and highlights disparities in healthcare access within these regions. These findings highlight the urgent need for targeted screening programmes, improved photoprotection strategies and culturally sensitive education initiatives to reduce morbidity and mortality among this vulnerable population.
References
1. King RA, Hearing VJ, Creel DJ, Oetting WS. Oculocutaneous albinism. In: Scriver CR, Beaudet AL, Sly
WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill,
2001:5587-5627. https://doi.org/10.1167/iovs.10-6091
2. Msomi V. Stark white: Experiences of learners with albinism (LWA) in primary and secondary schools
in the uMlazi District. Master of Education (Educational Psychology) thesis. Durban: University of
KwaZulu-Natal, 2014.
3. Cruz-Inigo AE, Ladizinski B, Sethi A. Albinism in Africa: Stigma, slaughter and awareness campaigns.
Dermatol Clin 2011;29(1):79-87. https://doi.org/10.1016/j.det.2010.08.015
4. Ero I. Report of the independent expert on the enjoyment of human rights by persons with albinism.
Geneva: United Nations, 2020.
5. Franklin A, Lund P, Bradbury-Jones C, Taylor J. Children with albinism in African regions: Their rights
to ‘being’ and ‘doing’. BMC Int Health Hum Rights 2018;18(1):2. https://doi.org/10.1186/s12914-018-
0144-8
6. Bradbury-Jones C, Ogik P, Betts J, Taylor J, Lund P. Beliefs about people with albinism in Uganda:
A qualitative study using the Common-Sense Model. PLoS ONE 2018;13(10):e0205774. https://doi.
org/10.1371/journal.pone.0205774
7. Duigan BLS, M. Surface UVB irradiance measurements at Durban during 1993. S Afr J Sci
1995;91:394-398.
8. Diffey BL. Solar ultraviolet radiation effects on biological systems. Physics Med Biol 1991;36(3):299-
328. https://doi.org/10.1088/0031-9155/36/3/001
9. Guy CY, Diab RD. A health risk assessment of ultraviolet radiation in Durban. S Afr Geographical J
2012;84(2):208-213. https://doi.org/10.1080/03736245.2002.9713772
10. Okulicz JF, Shah RS, Schwartz RA, Janniger CK. Oculocutaneous albinism. J Eur Acad Dermatol
Venereol 2003;17(3):251-256. https://doi.org/10.1046/j.1468-3083.2003.00767.x
11. Wright CY, Norval M, Hertle RW. Oculocutaneous albinism in sub-Saharan Africa: Adverse sunassociated
health effects and photoprotection. Photochem Photobiol 2015;91(1):27-32. https://doi.
org/10.1111/php.12359
12. Yakubu A, Mabogunje OA. Skin cancer in African albinos. Acta Oncol 1993;32(6):621-622.
13. Mswela MM. Living with albinism in South Africa: Uncovering the health challenges from a legal
perspective. Obiter 2022;43(1): 25-48.
14. Zungu Z, Mashige KP. Utilisation of eye and skin care, and social services among persons with
albinism in Ulundi, KwaZulu-Natal, South Africa. African Vision and Eye Health 2019;78(1):120-124.
https://doi.org/10.4102/aveh.v78i1.484
15. Castori M, Morrone A, Kanitakis J, Grammatico P. Genetic skin diseases predisposing to basal cell
carcinoma. Eur J Dermatol 2012;22(3):299-309. https://doi.org/10.1684/ejd.2011.1633
16. Mabula JB, Chalya PL, McHembe MD, et al. Skin cancers among albinos at a university teaching
hospital in Northwestern Tanzania: A retrospective review of 64 cases. BMC Dermatology 2012;12(1).
https://doi.org/10.1186/1471-5945-12-5
17. Lekalakala PT, Khammissa RA, Kramer B, Ayo-Yusuf OA, Lemmer J, Feller L. Oculocutaneous
albinism and squamous cell carcinoma of the skin of the head and neck in sub-Saharan Africa. J Skin
Cancer 2015;2015:167847. https://doi.org/10.1155/2015/167847
18. Ayanlowo OO, Adegbulu AA, Cole‐Adeife O. Cutaneous cancers in the Africans: Systematic review.
Dermatological Rev 2022;3(6):369-383. https://doi.org/10.1002%2Fder2.132
19. Higginson J, Oettle AG. Cancer incidence in the Bantu and ‘Cape Colored’ races of South Africa:
Report of a cancer survey in the Transvaal (1953-55). J Natl Cancer Inst 1960;24:589-671. https://doi.
org/10.1093/jnci/24.3.589
20. Hong ES, Zeeb H, Repacholi MH. Albinism in Africa as a public health issue. BMC Public Health
2006;6:212. https://doi.org/10.1186/1471-2458-6-212
21. Emadi SE, Juma Suleh A, Babamahmoodi F, Ahangarkani F, Betty Chelimo V, Mutai B, et al. Common
malignant cutaneous conditions among albinos in Kenya. Med J Islam Repub Iran 2017;31:3. https://
doi.org/10.18869/mjiri.31.3
22. Kiprono SK, Chaula BM, Beltraminelli H. Histological review of skin cancers in African Albinos:
A 10‑year retrospective review. BMC Cancer 2014;14:157. https://doi.org/10.1186/1471-2407-14-157
23. Makuru MH, Maruma F, Ngwenya E, Mponda K. Clinico-pathologic profile of skin cancers in
oculocutaneous albinism at Universitas Academic Hospital. Health SA 2025;30(0):2906. https://doi.
org/10.4102/hsag.v30i0.2906
24. Lund PM, Maluleke TG, Gaigher I, Gaigher MJ. Oculocutaneous albinism in a rural community
of South Africa: A population genetic study. Ann Hum Biol 2007;34(4):493-497. https://doi.
org/10.1080/03014460701401261
25. Kromberg JG, Jenkins T. Prevalence of albinism in the South African negro. S Afr Med J
1982;61(11):383-386.
26. Kromberg JGR. Epidemiology of albinism. Albinism in Africa 2018;13(2):57-79.
27. Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. Clin
Genet 1989;36(1):43-52.
28. Kromberg JGR, Flynn KA, Kerr RA. Determining a worldwide prevalence of oculocutaneous albinism:
A systematic review. Invest Ophthalmol Vis Sci 2023;64(10):14. https://doi.org/10.1167/iovs.64.10.14
29. Asuquo ME, Agweye P, Ugare G, Ebughe G. Basal cell carcinoma in five albino Africans from the
south-eastern equatorial rain forest of Nigeria. Int J Dermatol 2007;46(7):754-756. https://doi.
org/10.1111/j.1365-4632.2007.03272.x
30. Enechukwu NA, Ogun GO, Ezejiofor OI, et al. Histopathologic patterns of cutaneous malignancies
in individuals with oculocutaneous albinism in Anambra state, Nigeria: A paradigm swing?
Ecancermedicalscience 2020;14:1013. https://doi.org/10.3332/ecancer.2020.1013
31. Mouhari-Toure A, Akakpo SA, Teclessou JN, et al. Factors associated with skin cancers in people with
albinism in Togo. J Skin Cancer 2021;2021:3433493. https://doi.org/10.1155/2021/3433493
32. Inena G, Chu B, Falay D, et al. Patterns of skin cancer and treatment outcomes for patients with
albinism at Kisangani Clinic, Democratic Republic of Congo. Int J Dermatol 2020;59(9):1125-1131.
https://doi.org/10.1111/ijd.14988
33. Luande J, Henschke CI, Mohammed N. The Tanzanian human albino skin. Natural history.
Cancer 1985;55(8):1823-1828. https://doi.org/10.1002/1097-0142(19850415)55:8%3C1823::aidcncr2820550830%
3E3.0.co;2-x
34. Nakkazi E. People with albinism in Africa: Contending with skin cancer. Lancet 2019;394(10198):553-
554. https://doi.org/10.1016/s0140-6736(19)31941-5
35. Marçon Carolina R, Moraes José C, de Olivas Ferreira Marcus Antonio M, Oliari Camilla B.
Dermatological and epidemiological profiles of patients with albinism in São Paulo, Brazil, between 2010
and 2017: A cross-sectional study. Dermatology 2020;236(3):219-227. https://doi.org/10.1159/000502034
36. Okafor OC, Onyishi NT. Primary cutaneous malignancies in nonalbino and albino Africans. Int J
Dermatol 2021;60(2):222-228. https://doi.org/10.1111/ijd.15312
37. Traoré B, Barry A, Kourouma T, Keita M, Cisse M. Skin cancers in albinos at Surgical Oncology Unit of
Donka National Hospital (Conakry). Cancer Stud Therapeutics 2019;4(1):1-5.
38. Zongo N, Djiguemde AR, Yameogo PB, et al. Issues in the surgical management of skin squamous cell
cancers in albinos – experience of two surgical oncology units in Burkina Faso. World J Surgical Oncol
2023;21(1):323. https://doi.org/10.1186/s12957-023-03217-0
39. Enitan A, Atinuke A, Olasode O, et al. Pattern of cutaneous lesions in patients with oculocutaneous
albinism. NJD 2022;12(1):7-13.
40. Durojaye E, Nabaneh S. Human rights and access to healthcare for persons with albinism in Africa. Afr
Disability Rights Yearb 2019;7(2):35-58. http://doi.org/10.29053/2413-7138/2019/v7a2
41. Andrees V, Wolf S, Liebers J, Augustin M, Girbig G. Which factors influence the participation in
statutory skin cancer screenings in Germany? Journal der Deutschen Dermatologischen Gesellschaft
2024;22(6):775-781. https://doi.org/10.1111/ddg.15421
42. Kimlin MG, Tenkate TD. Occupational exposure to ultraviolet radiation: The duality dilemma. Revi
Environmen Health 2007;22(1):1-38. https://doi.org/10.1515/reveh.2007.22.1.1
43. Le Booysen F. Urban-rural inequalities in health care delivery in South Africa. Development South Afr
2003;20(5):659-673. https://10.1080/0376835032000149298
44. Saka B, Akakpo SA, Teclessou JN, et al. Skin cancers in people with albinism in Togo in 2019: Results
of two rounds of national mobile skin care clinics. BMC Cancer 2021;21(1):26. https://doi.org/10.1186/
s12885-020-07747-8
45. Onyishi N, Ohayi S. Cutaneous melanoma in African albinos: A systematic review. J Clin Diagnostic
Res 2021;15(11):WED1-WED6. https://doi.org/10.7860/JCDR/2021/51221.15675
46. Mahendraraj K, Sidhu K, Lau CSM, McRoy GJ, Chamberlain RS, Smith FO. Malignant melanoma in
African-Americans: A Population-based clinical outcomes study involving 1 106 African-American
patients from the Surveillance, Epidemiology, and End Result (SEER) database (1988-2011). Medicine
2017;96(15):e6258. https://doi.org/10.1097/md.0000000000006258
47. Tod BM, Kellett PE, Singh E, Visser WI, Lombard CJ, Wright CY. The incidence of melanoma in South
Africa: An exploratory analysis of National Cancer Registry data from 2005 to 2013 with a specific
focus on melanoma in black Africans. S Afr Med J 2019;109(4):246-253. https://doi.org/10.7196/
samj.2019.v109i4.13565
Downloads
Published
Issue
Section
License
Copyright (c) 2026 P Burge, A Madaree

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.




